| Description | Inaxaplin is an apolipoprotein L1 ( APOL1 ) function inhibitor. Inaxaplin can be used for the research of kidney disease. |
| In vitro | Inaxaplin是一种抑制apolipoprotein L1功能的化合物[1]。 |
| Synonyms | VX-147 |
| molecular weight | 417.38 |
| Molecular formula | C21H18F3N3O3 |
| CAS | 2446816-88-0 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
| Solubility | DMSO: 40 mg/mL (95.8 mM), Sonication is recommended. |
| References | 1. WO2020131807 |